The U.S. Department of Health and Human Services (HHS) has announced that it would provide the prescription flu treatment Tamiflu (oseltamivir phosphate) to jurisdictions with an elevated demand for the antiviral during the flu season. The move would make millions of treatment courses available. Roche is the developer of Tamiflu. Several generics are also available…